Order Article Reprints

Neutel JM, Erdem R, Jiang Q, Cannon K, Stacey H, Newton R, Gomme E, Li W, Mensa FJ, Türeci Ö, et al. Safety and Immunogenicity of Concomitant Administration and Combined Administration of Bivalent BNT162b2 COVID-19 Vaccine and Bivalent RSVpreF Respiratory Syncytial Virus Vaccine with or Without Quadrivalent Influenza Vaccine in Adults ≥ 65 Years of Age. Vaccines. 2025; 13(2):158. https://doi.org/10.3390/vaccines13020158

Neutel, Joel M., Rahsan Erdem, Qin Jiang, Kevin Cannon, Helen Stacey, Ryan Newton, Emily Gomme, Wen Li, Federico J. Mensa, Özlem Türeci, and et al. 2025. "Safety and Immunogenicity of Concomitant Administration and Combined Administration of Bivalent BNT162b2 COVID-19 Vaccine and Bivalent RSVpreF Respiratory Syncytial Virus Vaccine with or Without Quadrivalent Influenza Vaccine in Adults ≥ 65 Years of Age" Vaccines 13, no. 2: 158. https://doi.org/10.3390/vaccines13020158

Neutel, J. M., Erdem, R., Jiang, Q., Cannon, K., Stacey, H., Newton, R., Gomme, E., Li, W., Mensa, F. J., Türeci, Ö., Şahin, U., Swanson, K. A., Munjal, I., Cooper, D., Koury, K., Anderson, A. S., Gurtman, A., & Kitchin, N., on behalf of the C5481001 Study Group. (2025). Safety and Immunogenicity of Concomitant Administration and Combined Administration of Bivalent BNT162b2 COVID-19 Vaccine and Bivalent RSVpreF Respiratory Syncytial Virus Vaccine with or Without Quadrivalent Influenza Vaccine in Adults ≥ 65 Years of Age. Vaccines, 13(2), 158. https://doi.org/10.3390/vaccines13020158